J. Opacka-Juffry

发表

Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography

R. Myers, D. Brooks, A. Lammertsma, 1992, Synapse.

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter—In Silico and In Vitro Exploration of Dissociative Diarylethylamines

M. Sahai, J. Opacka-Juffry, C. Davidson, 2018, Brain sciences.

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances ( NPS ) and Their Discrimination by the Dopamine Transporter In Silico and In Vitro Exploration of Dissociative

M. Sahai, J. Opacka-Juffry, C. Davidson, 2018 .

Electroencephalography (EEG) Measures of Neural Connectivity in the Assessment of Brain Responses to Salient Auditory Stimuli in Patients with Disorders of Consciousness

J. Opacka-Juffry, V. Lord, J. Opacka‐Juffry, 2016, Front. Psychol..

Coexistence of Gonadotrophin‐Releasing Hormone and Galanin: Immunohisto‐chemical and Functional Studies

C. Montagnese, J. Opacka-Juffry, C. Coen, 1990, Journal of neuroendocrinology.

Modulatory Effects of Levodopa on D2 Dopamine Receptors in Striatum Assessed Using In Vivo Microdialysis and PET

S. Hume, J. Opacka-Juffry, J. Opacka‐Juffry, 2005 .

Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET

S. Hume, R. Ahier, J. Opacka-Juffry, 1998, Journal of Neural Transmission.

Nomifensine‐induced increased in extracellular striatal dopamine is enhanced by isoflurane anaesthesia

R. Ahier, J. Cremer, J. E. Cremer, 1991, Synapse.

Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.

R. Myers, D. Brooks, S. Luthra, 1996, Nuclear Medicine and Biology.

Early deprivation leads to long-term reductions in motivation for reward and 5-HT1A binding and both effects are reversed by fluoxetine

J. Feldon, C. Pryce, J. Opacka-Juffry, 2009, Neuropharmacology.

Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.

J. Opacka-Juffry, A. Arévalo-Martı́n, E. Molina-Holgado, 2017, Advances in pharmacology.

Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease

A. Sullivan, J. Opacka-Juffry, J. Pohl, 1997, Neuroscience Letters.

The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)

M. A. De Luca, M. Sahai, M. D. De Luca, 2020, Frontiers in Pharmacology.

Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances – The case of the benzofuran 5-MAPB

H. Weinstein, G. Khelashvili, M. Sahai, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Behind a Great Drug There Is a Great Scientist: The Discovery of a Treatment for Parkinson’s Disease

J. Opacka-Juffry, J. Opacka‐Juffry, 2020, Frontiers for Young Minds.